| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.53 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |